PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Methanolic leaf extract (DEME) administered to streptozotocin-induced diabetic rats showed antidiabetic properties [PMID:38463183]
Derieliptosides A-C inhibited the growth of Candida albicans and selectively inhibited Enterococcus faecalis and Staphylococcus aureus [PMID:36214693]
13-homo-13-oxa-6a,12a-dehydrorotenone suppressed growth in A549, HeLa, and MCF-7 cells, and showed cytotoxicity in Jurkat and NALM-6 leukaemia cells [PMID:41990396]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 41990396 (2026) — 13-Homo-13-oxa-6a, 12a-dehydrorotenoids from Derris elliptica. · Natural product research
- 2.PMID: 16787651 (2006) — Extraction of rotenone from Derris elliptica and Derris malaccensis by pressurized liquid extraction compared with maceration. · Journal of chromatography. A
- 3.PMID: 36214693 (2023) — Three new rotenoids from the stems of Derris elliptica and their anti-microbial activity. · Natural product research
- 4.PMID: 29039664 (2017) — Stereocontrolled Semisyntheses of Elliptone and 12aβ-Hydroxyelliptone. · Journal of natural products
- 5.PMID: 16713130 (2006) — Antimicrobial activity of the Derris elliptica, Derris indica and Derris trifoliata extractives.